PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
8.98%
Revenue growth above 1.5x NXPI's 3.21%. David Dodd would confirm if the firm has a unique advantage driving sales higher.
13.85%
Gross profit growth above 1.5x NXPI's 0.13%. David Dodd would confirm if the company's business model is superior in terms of production costs or pricing.
55.96%
Positive EBIT growth while NXPI is negative. John Neff might see a substantial edge in operational management.
34.61%
Positive operating income growth while NXPI is negative. John Neff might view this as a competitive edge in operations.
52.80%
Positive net income growth while NXPI is negative. John Neff might see a big relative performance advantage.
58.33%
Positive EPS growth while NXPI is negative. John Neff might see a significant comparative advantage in per-share earnings dynamics.
58.33%
Positive diluted EPS growth while NXPI is negative. John Neff might view this as a strong relative advantage in controlling dilution.
-4.00%
Both firms reduce share counts. Martin Whitman would compare buyback intensity relative to free cash flow generation.
-3.80%
Both reduce diluted shares. Martin Whitman would review each firm’s ability to continue repurchases and manage option issuance.
-0.68%
Dividend reduction while NXPI stands at 0.12%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
58.13%
OCF growth above 1.5x NXPI's 37.88%. David Dodd would confirm a clear edge in underlying cash generation.
131.71%
FCF growth 1.25-1.5x NXPI's 94.26%. Bruce Berkowitz would see if capex decisions or cost controls create a cash flow advantage.
-8.26%
Negative 10Y revenue/share CAGR while NXPI stands at 79.10%. Joel Greenblatt would question if the company is failing to keep pace with industry changes.
19.49%
5Y revenue/share CAGR under 50% of NXPI's 77.31%. Michael Burry would suspect a significant competitive gap or product weakness.
74.31%
Positive 3Y CAGR while NXPI is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
93.48%
10Y OCF/share CAGR at 75-90% of NXPI's 104.58%. Bill Ackman would demand strategic changes to close the gap in long-term cash generation.
35.53%
Below 50% of NXPI's 107.18%. Michael Burry would be alarmed about sustained underperformance in generating free operational cash.
148.63%
Positive 3Y OCF/share CAGR while NXPI is negative. John Neff might see a big short-term edge in operational efficiency.
107.17%
Net income/share CAGR above 1.5x NXPI's 36.73% over 10 years. David Dodd would confirm if brand, IP, or scale secure this persistent advantage.
-49.18%
Negative 5Y net income/share CAGR while NXPI is 328.95%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
669.14%
Positive short-term CAGR while NXPI is negative. John Neff would see a clear advantage in near-term profit trajectory.
195.47%
Below 50% of NXPI's 1254.96%. Michael Burry would suspect poor capital allocation or persistent net losses eroding long-term equity build-up.
-5.11%
Negative 5Y equity/share growth while NXPI is at 18.89%. Joel Greenblatt sees the competitor building net worth while this firm loses ground.
17.24%
Below 50% of NXPI's 42.98%. Michael Burry suspects a serious short-term disadvantage in building book value.
63.48%
Dividend/share CAGR of 63.48% while NXPI is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
26.48%
Below 50% of NXPI's 169.49%. Michael Burry worries the firm returns far less capital to shareholders over 5 years.
9.16%
Below 50% of NXPI's 20.43%. Michael Burry suspects the firm invests elsewhere or can’t match the competitor’s dividend policy.
12.15%
AR growth well above NXPI's 1.04%. Michael Burry fears inflated revenue or higher default risk in the near future.
-3.45%
Inventory is declining while NXPI stands at 0.47%. Joel Greenblatt sees potential cost and margin benefits if sales hold up.
-3.72%
Negative asset growth while NXPI invests at 0.28%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
0.31%
Under 50% of NXPI's 3.20%. Michael Burry raises concerns about the firm’s ability to build intrinsic value relative to its rival.
-3.22%
Both reduce debt yoy. Martin Whitman sees a broader sector shift to safer balance sheets or less growth impetus.
-0.40%
Our R&D shrinks while NXPI invests at 4.75%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
-1.45%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.